Gentian Diagnostics AS (OSL:GENT) EPS (Basic) : kr2.94 (TTM As of Dec. 2024)

View and export this data going back to 2016. Start your Free Trial

What is Gentian Diagnostics AS EPS (Basic)?

Gentian Diagnostics AS's basic earnings per share (Basic EPS) for the three months ended in Dec. 2024 was kr2.14. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Dec. 2024 was kr2.94.

Gentian Diagnostics AS's EPS (Diluted) for the three months ended in Dec. 2024 was kr2.09. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Dec. 2024 was kr2.87.

Gentian Diagnostics AS's EPS without NRI for the three months ended in Dec. 2024 was kr2.09. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Dec. 2024 was 2.87.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 12 years, Gentian Diagnostics AS's highest 3-Year average EPS without NRI Growth Rate was 21.30% per year. The lowest was -60.70% per year. And the median was -15.80% per year.

Gentian Diagnostics AS EPS (Basic) Historical Data

The historical data trend for Gentian Diagnostics AS's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Gentian Diagnostics AS EPS (Basic) Chart

Gentian Diagnostics AS Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

EPS (Basic)

Get a 7-Day Free Trial

-1.13

-1.61

-1.53

-0.69

2.94

Gentian Diagnostics AS Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
EPS (Basic)	Get a 7-Day Free Trial															-0.65	0.27	0.31	0.22	2.14

Gentian Diagnostics AS EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

Gentian Diagnostics AS's Basic EPS for the fiscal year that ended in Dec. 2024 is calculated as

Basic EPS (A: Dec. 2024 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(45.293	-	0)	/	15.422
	=	2.94

Gentian Diagnostics AS's Basic EPS for the quarter that ended in Dec. 2024 is calculated as

Basic EPS (Q: Dec. 2024 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(32.99	-	0)	/	15.422
	=	2.14

EPS (Basic) for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was kr2.94

Gentian Diagnostics AS (OSL:GENT) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

Gentian Diagnostics AS EPS (Basic) Related Terms

Thank you for viewing the detailed overview of Gentian Diagnostics AS's EPS (Basic) provided by GuruFocus.com. Please click on the following links to see related term pages.

Gentian Diagnostics AS Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Gentian Diagnostics AS (OSL:GENT) » Definitions » EPS (Basic)

Comparable Companies

Traded in Other Exchanges

N/A

Address

Bjornasveien 5, Moss, NOR, 1596

Website

https://www.gentian.com

Gentian Diagnostics AS operates as a medical diagnostics company in Norway. It develops and produces in-vitro diagnostic reagents (IVD) for use in medical diagnostics and research. Its portfolio and pipeline of reagents span areas of inflammations, severe infections, kidney diseases, heart failures, and veterinary healthcare. The company's product portfolio includes the Gentian Cystatin C Immunoassay, the GCAL circulating calprotectin immunoassay (IVDR), the Gentian Retinol Binding Protein (RBP), and the Gentian Canine CRP among others. Geographically, it generates a majority of its revenue from Europe followed by Asia and the United States of America.